Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma
3 clinical trials · Condition
◉ Watch Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer (NCT03575234) | Emory University | 2020-07-01 |
| Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma (NCT03799445) | M.D. Anderson Cancer Center | 2019-07-25 |
| New Modalities for Detection of Oropharyngeal Cancer (NCT03226613) | Vanderbilt University Medical Center | 2017-08-15 |
Track Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.